Drug Development Tools for Drug Metabolism

Dr. Mark Schurdak presented Qualification of Patient-derived Biomimetic Liver MPS as Drug Development Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing, and Clinical Trial Cohort Selection  at the 23rd NIH MPS World Summit being held in Seattle, Washington June 9-14, 2024